| Bioactivity | MG-2119 is a potent monomeric tau and α-syn aggregation inhibitor. MG-2119 is a potential agent for neurological disorders research[1]. |
| Target | tau and α-syn |
| Name | MG-2119 |
| CAS | 1065500-40-4 |
| Formula | C27H29N5O4 |
| Molar Mass | 487.55 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Gabr MT, et al. Dual Targeting of Monomeric Tau and α-Synuclein Aggregation: A New Multitarget Therapeutic Strategy for Neurodegeneration. ACS Chem Neurosci. 2020;11(14):2051-2057. |
MG-2119
CAS: 1065500-40-4 F: C27H29N5O4 W: 487.55
MG-2119 is a potent monomeric tau and α-syn aggregation inhibitor. MG-2119 is a potential agent for neurological disord
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.